RBC Capital raised the firm’s price target on Corteva to $64 from $56 and keeps an Outperform rating on the shares after its Q4 earnings beat. The analyst is also citing the firm’s expectation of mid-single-digit EBITDA growth in 2024, the management’s comfort with its 2025 EBITDA target range of $3.9B-$4.4B, and its focus on free cash flow and buybacks.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CTVA: